13:39 EDT Can-Fite BioPharma (CANF) trading halted, news pending
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CANF:
- Can-Fite Projects $685M Revenue from Partnerships
- Can-Fite BioPharma announces completion of analysis of current partnerships
- Can-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
- Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
- Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson